Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
11/2003
11/18/2003US6649386 Stability; for reconstitution with water; antihemophilic factor; blood factor IX
11/18/2003US6649384 Using polymer; atomizing, rotation
11/18/2003US6649193 Biomedically acceptable, cage-like compounds, including cobalamin (vitamin B12), potassium silicate and colloidal silicates and aluminosilicates such as zeolites encage atomic hydrogen in a
11/18/2003US6649192 Application of nanoparticles based on hydrophilic polymers as pharmaceutical forms
11/18/2003US6649191 Orally administrable compositions comprising cation cross-linked polysaccharide and a polymer digestible in the lower gastrointestinal tract
11/18/2003US6649189 Screening activities of eukaryotic tissues; obtain sample tissue, incubate with modulator, monitor cellular activity of tissues
11/18/2003US6649188 Highly flexible starch-based films
11/18/2003US6649187 For administering an amine drug such as (S-(R,S))-2-(4-(((4-methyl)piperazin-1-yl) carbonyl)phenoxy)-3,3-diethyl-N-(1-(3,4-methylenedioxyphenyl) butyl)-4-oxo-1-azetidinecarboxamide)
11/18/2003US6649186 Effervescent granules and methods for their preparation
11/18/2003US6649185 For the treatment of cancer; particularly, the formulation can be used to treat haematological malignancies
11/18/2003US6649184 Device and method for treating ophthalmic diseases
11/18/2003US6649183 Methods for treating apnea and apnea disorders using optically pure R(+) ondansetron
11/18/2003US6649180 Hard capsule formed of cellulose ether film with a specific content of methoxyl and hydroxypropoxyl groups
11/18/2003US6649172 5-(p-carboxybenzyloxy)-2-oxybenzaldehyde derivatives; vaccine adjuvants
11/18/2003US6649170 Adjuvant combinations for immunization composition and vaccines
11/18/2003US6649168 Pharmaceutical compositions comprising TGF-beta
11/18/2003US6649147 Delivery system for oral care compositions comprising organosiloxane resins using a removable backing strip
11/18/2003US6649145 Wound healing, treating infections
11/18/2003US6649011 Method for producing adhesive blanks form an endless band and blanks obtained according to said method
11/18/2003US6648821 Microprocessor controlled ambulatory medical apparatus with hand held communication device
11/18/2003US6647987 Insulin delivery enhanced by coached breathing
11/18/2003CA2274680C Process for manufacturing ophthalmic suspensions
11/18/2003CA2136071C 2-arylpropionic acid compositions and process for preparing the same
11/18/2003CA2109952C Pharmaceutical compositions
11/13/2003WO2003094092A1 Computer assisted remotely controled infusion therapy system
11/13/2003WO2003094091A1 Infusion therapy flow rate adjustment system and method
11/13/2003WO2003094075A1 Centralized medical device configuration system
11/13/2003WO2003093503A2 Method for bioequivalence determination using expression profiling
11/13/2003WO2003093449A2 Methods for delivery of nucleic acids
11/13/2003WO2003093344A1 Polymeric microemulsions
11/13/2003WO2003093337A1 Hydrogel of (semi)interpenetrating network structure and process for producing the same
11/13/2003WO2003093327A1 Gel having multiple network structure and method for preparation thereof
11/13/2003WO2003093196A1 Method of preparing porous calcium phosphate granules
11/13/2003WO2003092880A1 Microcapsules (xvii)
11/13/2003WO2003092852A1 Crystallization system utilizing atomization
11/13/2003WO2003092851A1 Preparation of small crystals
11/13/2003WO2003092785A1 Arrays of microneedles comprising porous calcium phosphate coating and bioactive agents
11/13/2003WO2003092767A2 A method for inhibiting platelet aggregation
11/13/2003WO2003092754A1 Ionically crosslinked alginate hydrogels, process for their manufacture and their use in medical devices
11/13/2003WO2003092741A1 Delivery of microparticle-conjugated drugs for inhibition of stenosis
11/13/2003WO2003092740A1 Non-viral gene delivery system
11/13/2003WO2003092734A1 Temperature responsive delivery systems
11/13/2003WO2003092732A1 Ph-sensitive polymer
11/13/2003WO2003092729A1 Stable pharmaceutical formulation for a combination of a statin and an ace inhibitor
11/13/2003WO2003092728A1 Encapsulated cells to elicit immune response
11/13/2003WO2003092707A1 Use of xenon for the control of neurological deficits associated with cardiopulmonary bypass
11/13/2003WO2003092706A1 Re-epithelializing pharmaceutical compositions comprising xanthan gum
11/13/2003WO2003092703A1 Methods and compositions for inhibition or irritation by disaccharide and metal ions
11/13/2003WO2003092697A1 Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith
11/13/2003WO2003092689A1 The treatment of pain with ifendropil
11/13/2003WO2003092680A1 New surfactant-based formulation containing triclabendazole
11/13/2003WO2003092677A1 Trans-epicutaneous administration form for treating restless leg syndrome
11/13/2003WO2003092673A1 Use of epa and dha in secondary prevention
11/13/2003WO2003092665A2 Ocular drug delivery systems and use thereof
11/13/2003WO2003092664A1 Micro-capsules with anti-acne active ingredients
11/13/2003WO2003092663A1 Colored hard capsules
11/13/2003WO2003092662A1 Fluid delivery device having an electrochemical pump with an anionic exchange membrane and associated method
11/13/2003WO2003092661A1 Multi-phasic delivery via transmucosal absorption of appetite suppressants and craving reduction medicaments
11/13/2003WO2003092660A1 Monocompartment osmotic controlled drug delivery system
11/13/2003WO2003092659A1 Oral dosage forms comprising fenofibrate
11/13/2003WO2003092658A1 A process for the preparation of tablets from pharmaceutically active substances having unfavourable tabletting properties with a granulating liquid comprising microcrystalline cellulose
11/13/2003WO2003092657A1 Microparticles bearing cells and active substances
11/13/2003WO2003092655A2 Use of active ingredient mixtures with azelaic acids and glycyrrhetic acids as anti-acne agents
11/13/2003WO2003092654A1 Formulations limiting spread of pulmonary infections
11/13/2003WO2003092653A1 Apparatus and method for delivery of bacteria to the vaginal tract
11/13/2003WO2003092652A1 Warming and nonirritating anhydrous lubricant compositions
11/13/2003WO2003092651A1 Warming and nonirritating lubricant compositions
11/13/2003WO2003092650A1 Warming and nonirritating lubricant antifungal gel compositions
11/13/2003WO2003092649A2 Reduced formate poly(alkylene oxides) with secondary amines for reducing impurity formation
11/13/2003WO2003092648A1 Methods and dosage forms for controlled delivery of oxycodone
11/13/2003WO2003092647A2 Transport system in biological systems
11/13/2003WO2003092641A1 Topical glycopyrrolate product
11/13/2003WO2003092640A2 Cosmetic product comprising at least one water-soluble copolymer which contains (meth)acrylamide units
11/13/2003WO2003092633A2 Diffusion-controlled dosage form and method of fabrication including three dimensional printing
11/13/2003WO2003092625A2 Carvedilol formulations
11/13/2003WO2003092623A2 Calicheamicin derivative-carrier conjugates
11/13/2003WO2003092621A2 Composition and method for dermatological treatment
11/13/2003WO2003092596A2 TREATING ECZEMA WITH A COMBINATION OF ISOTONIC SALINE OCEANè AND MAST CELL STABILIZERS
11/13/2003WO2003092591A2 Multi-phasic delivery via transmucosal absorption of antiemetic medicaments
11/13/2003WO2003092590A2 Formulations containing amiodarone and sulfoalkyl ether cyclodextrin
11/13/2003WO2003092585A2 Controlled release compositions of estradiol metabolites
11/13/2003WO2003092514A1 Device and method for treating conditions of a joint
11/13/2003WO2003092400A1 Sugar-free hard coatings prepared from liquid maltitol comprising dp4+ fraction
11/13/2003WO2003092379A1 Fatty acid containing teat dip
11/13/2003WO2003080056A3 Fine particle size pioglitazone
11/13/2003WO2003077883A3 Composition and utilization thereof for forming a protective film on nasal mucous membranes
11/13/2003WO2003075788A3 Biodegradable microbicidal vaginal barrier device
11/13/2003WO2003066001A3 Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
11/13/2003WO2003063839A8 Bioadhesive composition comprising a polysaccharide and a polycarboxylated polymer
11/13/2003WO2003063822A3 Method for making homogeneous spray-dried solid amorphous drug dispersions utilizing modified spray-drying apparatus
11/13/2003WO2003063821A3 Method for making homogeneous spray-dried solid amorphous drug dispersions using pressure nozzles
11/13/2003WO2003061554A3 Composition containing moutan root bark extract as active ingredient
11/13/2003WO2003057175A3 Amine functionalized superparamagnetic nanoparticles for the synthesis of bioconjugates and uses therefor
11/13/2003WO2003045327A3 Efavirenz tablet formulation having unique biopharmaceutical characteristics
11/13/2003WO2003045305A3 Acetaminophen compositions
11/13/2003WO2003043585A3 Improved particulate compositions for pulmonary delivery
11/13/2003WO2003042113A8 Production of cell suspensions
11/13/2003WO2003041648A3 High-concentration lidocaine compositions and methods for their preparation
11/13/2003WO2003039444A3 Topical use of cytokines and/or chemokines for the treatment of viral or mykotic skin diseases or tumoral diseases
11/13/2003WO2003037398A3 Improved stent coating
1 ... 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 2080 2081 2082 2083 2084 2085 2086 2087 ... 2991